Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm to Offer Coronavirus Saliva Test to US Colleges, Universities at Low Cost

NEW YORK — Fluidigm said on Thursday that it has launched a program to provide millions of its saliva-based SARS-CoV-2 tests to US colleges and universities at low cost.

Fluidigm's Advanta Dx SARS-CoV-2 RT-PCR assay, which received Emergency Use Authorization from the US Food and Drug Administration in August, is designed to run on the company's Biomark HD microfluidics platform. Late last month, Fluidigm finalized a contract with the National Institutes of Health that will provide the company with up to $34 million in funding to support production of the test.

Under the newly announced Fluidigm COVID-19 Campus Safeguard Program, the South San Francisco, California-based company will provide the SARS-CoV-2 assay to colleges and universities across the country for as low as $5 a test.

The company said that it has a "large number" of Biomark HD placements in academic clinical labs in the US that meet the requirements to run its test in significant numbers including ones at the University of Pennsylvania; Washington University in St. Louis; OU Medicine, the University of Oklahoma, and the Oklahoma Medical Research Foundation.

Fluidigm President and CEO Chris Linthwaite said in a statement that the company is ramping up production of the Advanta Dx SARS-CoV-2 test and expects to have 6 million available by the end of the fourth quarter.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.